Women's Health Consortium Sets AI Standards as Diagnostic Gaps Persist
Maternal health company Willow and women's health platform Ema launched The Women's Health AI Consortium, a new governing body focused on large language models used in women's care. The consortium will establish standards for ethics, safety, bias, cultural sensitivity, and the balance between emotional and clinical quality in AI-enabled healthcare.
The move addresses a documented problem: 60% of women receive false diagnoses from AI tools, according to the consortium's findings.
Why the Data Gap Matters
Women weren't required to be included in clinical research until 1993. That gap persists today. Most AI chatbots rely on datasets skewed toward male physiology, leaving them ill-equipped to handle the clinical context of women's health.
The consequences are measurable. Seventy-five percent of women skip medical appointments due to barriers to care. Fifty-three percent then turn to AI for health advice despite knowing its limitations, according to Talker Research.
Companies Building Female-Focused AI
Several health companies are betting on women-only AI engines rather than generic models:
- Oura launched a targeted AI health coach
- WHOOP added female-focused Advanced Labs
- Midi Health built an LLM platform for research, patient personalization, and backend operations
These tools aim to deliver precision care by feeding AI systems the right clinical parameters for female biology, rather than applying one-size-fits-all models.
The consortium's framework raises the bar for AI for Healthcare by establishing patient confidence and improved outcomes. For healthcare professionals, understanding how Generative AI and LLM systems are being tailored to specific populations will shape how these tools are deployed in clinical settings.
Your membership also unlocks:
